← Leaderboards
Amol M Patwardhan
University Of Arizona
$3,341,711
Attributed
$3,674,097
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,674,097 · 3
By mechanism
R01$2,686,977 · 2
K08$987,120 · 1
Top collaborators
- Rajesh Khanna1 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Tony L Yaksh$23,138,803
- Frank Porreca$26,550,739
- Aleeca F Bell$2,531,373
Others in their field
Other Emerging Leaders on “Non-Opioid Analgesic”
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Bryan L McLaughlin · Micro-Leads, Inc.$10,201,646
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Kristen Leann Gullo · Us Worldmeds, Llc$5,806,657
Research focus
Non-Opioid AnalgesicPeptidesNeurotensin ReceptorsIn VivoOpioidPainGranulomaNeurotensinDrug Delivery SystemsElectrophysiology (Science)MotorAnalgesicsMediatingLocal AnestheticsAfferent NeuronsCrispr/Cas TechnologyAcuteDorsal HornAgonistCalcium ChannelAbsence Of Pain SensationDrug KineticsBreakthrough PainPharmaceutical Preparations
Grant awards (10)
Dissection of NTSR2/calcium channel signaling as a non-opioid spinal analgesic mechanism for the treatment of high impact chronic pain$664,772
R01 · FY2025 · NS · contact PI
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target$396,939
R01 · FY2025 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$141,354
K08 · FY2022 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$56,286
K08 · FY2022 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$197,640
K08 · FY2021 · NS · contact PI
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target$1,461,204
R01 · FY2020 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$197,640
K08 · FY2020 · NS · contact PI
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target$164,062
R01 · FY2020 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$197,640
K08 · FY2019 · NS · contact PI
Mechanism of intrathecal Contulakin-G induced analgesia without motor block$196,560
K08 · FY2018 · NS · contact PI